Real-world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma. [electronic resource]
- Asia-Pacific journal of clinical oncology Feb 2019
- 26-30 p. digital
Publication Type: Journal Article
1743-7563
10.1111/ajco.13100 doi
Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols--therapeutic use Brain Neoplasms--drug therapy Female Humans Ipilimumab--administration & dosage Male Melanoma--drug therapy Middle Aged Nivolumab--administration & dosage Prognosis Retrospective Studies Survival Rate Young Adult